Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
When researchers treated mice with an immune checkpoint inhibitor, they found an unexpected result.
Early research in animals shows potential against cervical cancer and neuroblastoma.
The novel treatment is successful for blood cancers, but results in patients with solid tumors have not been nearly as impressive.
Maintaining blood sugar levels and minimizing possible diabetic complications can have a positive impact on colorectal cancer outcomes.
Oncolytic viruses thrive inside cancer cells.
Shivani Srivastava receives NCI MERIT Award to investigate how to improve engineered cancer immunotherapies against solid tumors.
EBV causes chromosome breakage that can trigger a cascade of genomic instability leading to tumor growth.
Researchers sought to understand both neuroendocrine tumors themselves and the surrounding cells in the tumor microenvironment.
A collaboration explores canine sinonasal carcinoma with the aim of better treatment options for humans — and our canine companions.
An AI–based tool can evaluate photos of kidney tumor samples and may help predict treatment responses, report Dana-Farber researchers.
A Lung Cancer Diary with Hank Baskett, 79, who was diagnosed with Stage IV ALK+ non-small-cell lung cancer in 2011.
The results were extraordinary, with participants experiencing an average 90% reduction in tumor size.
Inherited genetic determinants can cause normal variations in PSA levels even in the absence of prostate cancer
New approach could provide insights into cancer progression and treatment response, leading to more precise therapies.
Bladder cells’ strategy blocks cancer-causing genetic programs, could be new therapeutic target.
It turns out that some cancer cells can proliferate without upping their energy production.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.